Skip to main content Accessibility help
×
Home
  • Print publication year: 2014
  • Online publication date: December 2014

10 - Human prion diseases

References

1. S. B. Prusiner. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136–44.
2. J. W. Ironside, B. Ghetti, M. W. Head, P. Piccardo, R. G. Will. Prion diseases. In: S. Love, D. N. Louis, D. W. Ellison (eds). Greenfield’s Neuropathology, 8th edn. London, Hodder Arnold, 2008; 1197–273.
3. M. W. Head, J. W. Ironside. Creutzfeldt–Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol 2012; 83: 296–310.
4. J. E. Bell, S. M. Gentleman, J. W. Ironside, et al. Prion protein immunocytochemistry-UK five centre consensus report. Neuropathol Appl Neurobiol 1997; 23: 26–35.
5. M. W. Head, H. M. Yull, D. L. Ritchie, et al. Variably protease-sensitive prionopathy in the UK: a retrospective review 1991–2008. Brain 2013; 136: 1102–15.
6. M. W. Head MW, D. Ritchie, N. Smith N, et al. Peripheral tissue involvement in sporadic, iatrogenic and variant Creutzfeldt–Jakob disease: an immunohistochemical, quantitative and biochemical study. Am J Pathol 2004; 164: 143–53.
7. D. L. Ritchie, M. W. Head, J. W. Ironside. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt–Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol Appl Neurobiol 2004; 30: 360–68.
8. A. F. Hill, S. Joiner, J. D. F. Wadsworth, et al. Molecular classification of sporadic Creutzfeldt–Jakob disease. Brain 2003; 126: 1333–46.
9. H. M. Yull, D. L. Ritchie, J. P. M. Langeveld, et al. Detection of type 1 prion protein in variant Creutzfeldt–Jakob disease. Am J Pathol 2006; 168: 151–57.
10. P. Parchi, A. Giese, S, Capellari, et al. Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224–33.
11. P. Parchi, S. Capellari, S. G. Chen, et al. Typing prion isoforms. Nature 1997; 386: 232–34.
12. J. D. F. Wadsworth, S. Joiner, A. F. Hill, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt–Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358: 171–180.
13. A. H. Peden, M. W. Head, D. L. Ritchie, J. E. Bell, J. W. Ironside. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527–9.
14. A. H. Peden, L. McCardle, M. W. Head, et al. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010; 16: 296–304.
15. J. Safar, M. D. Geschwind, C. Deering, et al. Diagnosis of human prion diseases. Proc Natl Acad Sci USA 2005; 102: 3501–6.
16. G. P. Saborio, B. Permanne, C. Soto. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411: 810–13.
17. R. Atarashi, R. A. Moore, V. L. Sim, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 2007; 4: 645–50.
18. L. I. McGuire, A. H. Peden, C. D. Orru, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease. Ann Neurol 2012; 72: 278–85.
19. M. E. Bruce, I. McConnell, R. G. Will, J. W. Ironside. Detection of variant Creutzfeldt–Jakob disease infectivity in extraneural tissues. Lancet 2001; 358: 208–9.
20. M. E. Bruce, R. G. Will, J. W. Ironside, et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 1997; 389: 498–501.
21. G. C. Telling. Transgenic mouse models and prion strains. Top Curr Chem 2011: 305, 79–99.
22. P. Brown, C. J. Gibbs, P. Rodgers-Johnson, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513–29.
23. National Creutzfeldt–Jakob Disease Research & Surveillance Unit. Data and Reports. 2014. http://www.cjd.ed.ac.uk/data.html. (Accessed July 28, 2014).
24. World Health Organization. Infection Control Guidelines for Transmissible Spongiform Encephalopathies. 2003. http://who.int/csr/resources/publications/bse/whocdscsraph2003.pdf. (Accessed January 20, 2014).
25. H. Budka, M. W. Head, J. W. Ironside, et al. Sporadic Creutzfeldt–Jakob Disease. In: D. W. Dickson, R. O. Weller (eds). Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders. Oxford, Wiley-Blackwell, 2011; 322–35.
26. P. Parchi, R. Strammiello, S. Notari, et al. Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 2009; 118: 659–71.
27. P. Gambetti, Z. Dong, J. Yuan, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 2008; 63: 697–708.
28. W. Q. Zou, G. Puoti, X. Xiao, et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 2010; 68: 162–72.
29. P. Parchi, P. Gambetti, S. Capellari. Genetic Creutzfeldt–Jakob disease. In: D. W. Dickson, R. O. Weller (eds). Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders. Oxford, Wiley-Blackwell, 2011; 336–55.
30. B. Ghetti, F. Tagliavini, G. G. Kovacs, P. Piccardo. Gerstmann–Sträussler–Scheinker disease. In: D. W. Dickson, R. O. Weller (eds). Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders. Oxford, Wiley-Blackwell, 2011; 364–77.
31. P. Parchi, S. Capellari, P. Gambetti. Fatal familial and sporadic insomnia. In: D. W. Dickson, R. O. Weller (eds). Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders. Oxford, Wiley-Blackwell, 2011; 346–9.
32. J. W. Ironside, R. S. G. Knight, M. W. Head. Iatrogenic Creutzfeldt–Jakob disease. In: D. W. Dickson, R. O. Weller (eds). Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders. Oxford, Wiley-Blackwell, 2011; 381–86.
33. R. G. Will, J. W. Ironside, M. Zeidler, et al. A new variant of Creutzfeldt–Jakob disease in the UK. Lancet 1996; 347: 921–5.
34. J. W. Ironside, M. W. Head, R. G. Will. Variant Creutzfeldt–Jakob disease. In: D. W. Dickson, R. O. Weller (eds). Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders. Oxford, Wiley-Blackwell, 2011; 354–63.
35. M. T. Bishop, A. B. Diack, D. L. Ritchie, et al. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt–Jakob disease. Brain 2013; 136: 1139–45.
36. D. A. Hilton, A. C. Ghani, L. Conyers, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203: 733–9.
37. O. N. Gill, Y. Spencer, A. Richard-Loendt, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. Brit Med J 2013; 347: f5675.
38. C. A. McLean. Kuru. In: D. W. Dickson, R. O. Weller (eds). Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders. Oxford, Wiley-Blackwell, 2011; 378–80.
39. J. A. Edgeworth, M. Farmer, A. Sicilia, et al. Detection of prion infection in variant Creutzfeldt–Jakob disease: a blood-based assay. Lancet 2011; 377; 487–93.
40. F. Properzi, M. Pocchiari. Identification of misfolded proteins in body fluids for the diagnosis of prion diseases. Int J Cell Biol 2013, 839329.
41. S. B. Prusiner. Biology and genetics of prions causing neurodegeneration. Ann Rev Genet 2013; 47: 601–23.